Thrombocytopenia associates with the severity of inflammation and variables reflecting capillary leakage in Puumala Hantavirus infection, an analysis of 546 Finnish patients

References

• Brummer-Korvenkontio M, Vaheri A, Hovi T, et al. Nephropathia epidemica: detection of antigen in bank voles and serologic diagnosis of human infection. J Infect Dis. 1980;141:131–134.
   PubMed Web of Science ®Google Scholar
• Mustonen J, Mäkelä S, Outinen T, et al. The pathogenesis of nephropathia epidemica: new knowledge and unanswered questions. Antiviral Res. 2013;100:589–604.
   PubMed Web of Science ®Google Scholar
• Clement J, Maes P, Lagrou K, et al. A unifying hypothesis and a single name for a complex globally emerging infection: hantavirus disease. Eur J Clin Microbiol Infect Dis. 2012;31:1–5.
   PubMed Web of Science ®Google Scholar
• Heyman P, Vaheri A. Situation of hantavirus infections and haemorrhagic fever with renal syndrome in European countries as of December 2006. Euro Surveill. 2008;13:18925.
   PubMedGoogle Scholar
• Makary P, Kanerva M, Ollgren J, et al. Disease burden of Puumala virus infections, 1995–2008. Epidemiol Infect. 2010;138:1484–1492.
   PubMed Web of Science ®Google Scholar
• Mustonen J, Partanen J, Kanerva M, et al. Genetic susceptibility to severe course of nephropathia epidemica caused by Puumala hantavirus. Kidney Int. 1996;49:217–221.
   PubMed Web of Science ®Google Scholar
• Laine O, Joutsi-Korhonen L, Mäkelä S, et al. Polymorphisms of PAI-1 and platelet GP Ia may associate with impairment of renal function and thrombocytopenia in Puumala hantavirus infection. Thromb Res. 2012;129:611–615.
   PubMed Web of Science ®Google Scholar
• Mustonen J, Brummer-Korvenkontio M, Hedman K, et al. Nephropathia epidemica in Finland: a retrospective study of 126 cases. Scand J Infect Dis. 1994;26:7–13.
   PubMed Web of Science ®Google Scholar
• Valtonen M, Kauppila M, Kotilainen P, et al. Four fatal cases of nephropathia epidemica. Scand J Infect Dis. 1995;27:515–517.
   PubMed Web of Science ®Google Scholar
• Laine O, Mäkelä S, Mustonen J, et al. Enhanced thrombin formation and fibrinolysis during acute Puumala hantavirus infection. Thromb Res. 2010;126:154–158.
   PubMed Web of Science ®Google Scholar
• Laine O, Mäkelä S, Mustonen J, et al. Platelet ligands and ADAMTS13 during Puumala hantavirus infection and associated thrombocytopenia. Blood Coagul Fibrinolysis. 2011;22:468–472.
   PubMed Web of Science ®Google Scholar
• Rasche FM, Uhel B, Kruger DH, et al. Thrombocytopenia and acute renal failure in Puumala hantavirus infections. Emerging Infect Dis.2004;10:1420–1425.
   PubMed Web of Science ®Google Scholar
• Latus J, Kitterer D, Segerer S, et al. Severe thrombocytopenia in hantavirus-induced nephropathia epidemica. Infection. 2015;43:83–87.
   PubMed Web of Science ®Google Scholar
• Latus J, Schwab M, Tacconelli E, et al. Acute kidney injury and tools for risk-stratification in 456 patients with hantavirus-induced nephropathia epidemica. Nephrol Dial Transplant. 2015;30:245–251.
   PubMed Web of Science ®Google Scholar
• Wang M, Wang J, Wang T, et al. Thrombocytopenia as a predictor of severe acute kidney injury in patients with Hantaan virus infections. PLoS One. 2013;8:e53236.
   PubMed Web of Science ®Google Scholar
• Outinen TK, Mäkelä S, Clement J, et al. Community acquired severe acute kidney injury caused by hantavirus-induced hemorrhagic fever with renal syndrome has a favorable outcome. Nephron. 2015;130:182–190.
   PubMed Web of Science ®Google Scholar
• Libraty DH, Mäkelä S, Vlk J, et al. The degree of leukocytosis and urine gata-3 mrna levels are risk factors for severe acute kidney injury in puumala virus nephropathia epidemica. PLoS One. 2012;7:e35402.
   PubMed Web of Science ®Google Scholar
• Outinen TK, Kuparinen T, Jylhävä J, et al. Plasma cell-free DNA levels are elevated in acute Puumala hantavirus infection. PLoS One. 2012;7:e31455.
   PubMed Web of Science ®Google Scholar
• Outinen TK, Mäkelä S, Huhtala H, et al. High pentraxin-3 plasma levels associate with thrombocytopenia in acute Puumala hantavirus-induced nephropathia epidemica. Eur J Clin Microbiol Infect Dis. 2012;31:957–963.
   PubMed Web of Science ®Google Scholar
• Outinen TK, Mäkelä SM, Ala-Houhala IO, et al. High activity of indoleamine 2,3-dioxygenase is associated with renal insufficiency in Puumala hantavirus induced nephropathia epidemica. J Med Virol. 2011;83:731–737.
   PubMed Web of Science ®Google Scholar
• Outinen TK, Mäkelä SM, Ala-Houhala IO, et al. The severity of Puumala hantavirus induced nephropathia epidemica can be better evaluated using plasma interleukin-6 than C-reactive protein determinations. BMC Infect Dis. 2010;10:132.
   PubMed Web of Science ®Google Scholar
• Outinen TK, Tervo L, Mäkelä S, et al. Plasma levels of soluble urokinase-type plasminogen activator receptor associate with the clinical severity of acute Puumala hantavirus infection. PLoS One. 2013;8:e71335.
   PubMed Web of Science ®Google Scholar
• Paakkala A, Lempinen L, Paakkala T, et al. Medical imaging in nephropathia epidemica and their clinical correlations. Eur J Intern Med. 2004;15:284–290.
   PubMedGoogle Scholar
• Paakkala A, Mäkelä S, Hurme M, et al. Association of chest radiography findings with host-related genetic factors in patients with nephropathia epidemica. Scand J Infect Dis. 2008;40:254–258.
   PubMed Web of Science ®Google Scholar
• Mustonen J, Helin H, Pietilä K, et al. Renal biopsy findings and clinicopathologic correlations in nephropathia epidemica. Clin Nephrol. 1994;41:121–126.
   PubMed Web of Science ®Google Scholar
• Mustonen J, Partanen J, Kanerva M, et al. Association of HLA B27 with benign clinical course of nephropathia epidemica caused by Puumala hantavirus. Scand J Immunol. 1998;47:277–279.
   PubMed Web of Science ®Google Scholar
• Laine O, Joutsi-Korhonen L, Lassila R, et al. Hantavirus infection-induced thrombocytopenia triggers increased production but associates with impaired aggregation of platelets except for collagen. Thromb Res. 2015;136:1126–1132.
   PubMed Web of Science ®Google Scholar
• Sane J, Laine O, Mäkelä S, et al. Complement activation in Puumala hantavirus infection correlates with disease severity. Ann Med. 2012;44:468–475.
   PubMed Web of Science ®Google Scholar
• Vapalahti O, Kallio-Kokko H, Narvanen A, et al. Human B-cell epitopes of Puumala virus nucleocapsid protein, the major antigen in early serological response. J Med Virol. 1995;46:293–303.
   PubMed Web of Science ®Google Scholar
• Hedman K, Vaheri A, Brummer-Korvenkontio M. Rapid diagnosis of hantavirus disease with an IgG-avidity assay. Lancet. 1991;338:1353–1356.
   PubMed Web of Science ®Google Scholar
• Vapalahti O, Lundkvist Å, Kallio-Kokko H, et al. Antigenic properties and diagnostic potential of Puumala virus nucleocapsid protein expressed in insect cells. J Clin Microbiol. 1996;34:119–125.
   PubMed Web of Science ®Google Scholar
• Connolly-Andersen AM, Sundberg E, Ahlm C, et al. Increased thrombopoiesis and platelet activation in hantavirus-infected patients. J Infect Dis. 2015;212:1061–1069.
   PubMed Web of Science ®Google Scholar
• Koskela SM, Laine OK, Paakkala AS, et al. Spleen enlargement is a common finding in acute Puumala hantavirus infection and it does not associate with thrombocytopenia. Scand J Infect Dis. 2014;46:723–726.
   PubMed Web of Science ®Google Scholar
• Connolly-Andersen AM, Thunberg T, Ahlm C. Endothelial activation and repair during hantavirus infection: association with disease outcome. Open Forum Infect Dis. 2014;1:ofu027.
   PubMedGoogle Scholar
• Gavrilovskaya IN, Gorbunova EE, Mackow ER. Pathogenic hantaviruses direct the adherence of quiescent platelets to infected endothelial cells. J Virol. 2010;84:4832–4839.
   PubMed Web of Science ®Google Scholar
• Goeijenbier M, Meijers JC, Anfasa F, et al. Effect of Puumala hantavirus infection on human umbilical vein endothelial cell hemostatic function: platelet interactions, increased tissue factor expression and fibrinolysis regulator release. Front Microbiol. 2015;6:220.
   PubMed Web of Science ®Google Scholar
• Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8:R204–R212.
   PubMed Web of Science ®Google Scholar
• Willemann MC, Oliveira SV. Risk factors associated with hantavirosis fatality: a regional analysis from a case-control study in Brazil. Rev Soc Bras Med Trop. 2014;47:47–51.
   PubMed Web of Science ®Google Scholar
• Korva M, Saksida A, Kunilo S, et al. HLA-associated hemorrhagic fever with renal syndrome disease progression in slovenian patients. Clin Vaccine Immunol. 2011;18:1435–1440.
   PubMed Web of Science ®Google Scholar
• Borges AA, Donadi EA, Campos GM, et al. Association of -308G/A polymorphism in the tumor necrosis factor-alpha gene promoter with susceptibility to development of hantavirus cardiopulmonary syndrome in the Ribeirao Preto region, Brazil. Arch Virol. 2010;155:971–975.
   PubMed Web of Science ®Google Scholar